medigraphic.com
ISSN 2448-5640 (Print)
Diario Oficial de la Sociedad Mexicana de Cirugía Cardiaca, A.C., y del Colegio Mexicano de Cirugía Cardiovascular y Torácica, A.C.

2017, Number 4

Next >>

Cir Card Mex 2017; 2 (4)

Uso del parche de Novick en cardiopatía congénita con hipertensión pulmonar

Riera-Kinkel C, Espinosa-Díaz A, Cruz-Guerrero M, Ramírez-Castañeda A, Yáñez-Gutiérrez L, Márquez-González H

Language: Spanish
References: 22
Page: 111-119
PDF size: 224.08 Kb.


ABSTRACT

Objective. To describe postoperative clinic evolution of patients with pulmonary hypertension using Novick patch for surgical closure.
Materials and Methods. We found 21 patients with congenital heart disease undergoing Novick patch in an eleven-year period, from January 2005 to June 2016 in our institution. We use descriptive statistic analysis.
Results. Of the 21 patients most were female adults, the functional class was significantly improve with a 47.6% of the patients in functional class I (p<0.05), pulmonary hypertension crisis presented in 48%, the mortality rate was 14.3% and a 5 year survival rate of 85%.
Conclusions. The use of Novick patch is a highly reproducible technique that allows patients better postsurgical adaption and improves quality of life and survival.


REFERENCES

  1. Calderón-Colmereo J, Cervantes-Salazar J, Curi-Curi Pedro, Ramírez-MarroquínS. Problemática de las cardiopatías congénitas en México. Propuesta de regionalización.Arch Cardiol Mex 2010;80: 133-140.

  2. Calderón-Colmenero J, Sandoval J, Beltrán M. Hipertensión pulmonar asociada acardiopatías congénitas y síndrome de Eisenmenger. Arch Cardiol Mex 2015; 85:32-49.

  3. Marquez-Gonzalez H, Yañez-Gutierrez L, López-Gallegos D, Riera-Kinkel C.Empleo del parche valvado en el tratamiento de la comunicación interauricular enpacientes con hipertensión arterial pulmonar grave. Estudio cuasi-experimental.Cor Salud 2015;7:195-201.

  4. Attie, Calderon, Zabal, Buendia. Cardiología Pediátrica 2°ed. México, D.F. Ed.Medica Panamericana, 2013.

  5. Mohan Rao P, Raju V, Narayana M. Flap valved closure of ventricular septal defectswith increased pulmonary vascular resistance. Interact CardioVasc ThoracSurg 2010; 11: 577-80.

  6. Khairy M, El-Khateeb F. Unidirectional valved pericardial patch and sildenafiltherapy for repair of adult atrial septal defects with pulmonary hypertension. Journalof the Egyptian Society of Cardio-Thoracic Surgery 2011; 19: 123-7.

  7. Hawort S, Rabinovitch M. Cap. 7 Pulmonary Circulation En: Anderson R, BakerE, Penny D, Redington A, Rigby M, Wernovsky G. Paediatric Cardiology. Section1 Structural and functional development, 3°ed. Philadelphia, PA, USA. Ed. ChurchillLivingstone, 2010, P. 128

  8. Baumgartner H, Bonhoeffer P, De Groot N, et al. ESC Guidelines for the managementof grown-up heart disease (new version 2010). European Heart Journal 2010;31: 2915-57.

  9. Gah H, Zhang J, Zhang Z, et al. The unidirectional valve patch provides no benefitsto early and long-term survival in patients with ventricular septal defect andsevere pulmonary artery hypertension. J Thorac Cardiovasc Surg 2010; 139:950-5.

  10. Rivera-Rosales R. Histología y fisiopatogenia de la hipertensión pulmonar. RevInst Nal Enf Resp Mex 2004;17: S17-27.

  11. Rabinovitch M, Keane J, Norwood W, Castañeda A, Reid L. Vascular structure inlung tissue obtained at biopsy correlated with pulmonary hemodynamic findingsafter repair of congenital heart defects. Circulation 1984; 69: 655-67.

  12. Viswanathan S, Kumar K. Assessment of operability of congenital cardiacshunts with increased pulmonary vascular resistance. Catheter Cardiovasc Interv.2008;71:665-70.

  13. Janjua A, Saleem K, Khan I, Rashid A, Khan A, Hussain A. Double flap patchclosure of VSD with elevated pulmonary vascular resistance: an experience atAFIC/NIHD. Journal of the College of Physicians and Surgeons Pakistan 2011;21:197-201.

  14. Novick W M, Sandoval N, Lazorhysynets V, et al. Flap valve double patch closureof ventricular septal defects in children with increased pulmonary vascular resistance.Ann Thorac Surg 2005;79:21-8.

  15. Khan I, Ahmed I, Mufti W, et al. Ventricular septal defect in infants and childrenwith increased pulmonary vascular resistance and pulmonary hypertension.Surgical management: leaving an atrial level communication. J Ayub Med CollAbbottabad 2005;18: 21-5.

  16. Talwar S, Choudhary S, Saxena A, Kothari S, Juneja R, Airan B. Unidirectionalvalved patches for closure of septal defects in patients with severe pulmonaryhypertension. Ann Pediatr Card 2008;1:114-9.

  17. Talwar S, Choudhary S, Garg S, et al. Unidirectional valved patch closure of septaldefects in patients with severe pulmonary arterial hypertension. Interact Cardio-Vasc Thorac Surg 2012;1: 699-703.

  18. Choudhary S, Talwar S, Airan B. A simple technique of unidirectional valvedpatch for closure of septal defects. J Thorac Cardiovasc Surg 2007; 134:1357-8.

  19. Glovenko OS, Novick WM, Siromakha SO, Lazaryshynets W. VSD repair in patientsafter previous failed pulmonary artery banding. J Cardiothorac Surg 2013; 8(Suppl 1): 94.

  20. Manatomo, T. Pulmonary arterial hypertension in adults with atrial septal defect.Journal of Cardiology Cases 2012; 6: e32-3.

  21. Adatia I. Cap 44. Pulmonary Vascular Disease. En Freedom R, Yoo S-J, MakailianH, Williams W. The Natural and Modified History of Congenital Heart Disease.1° ed. New York, US Ed. Blackwell Publishing, 2004, pp. 518-52.

  22. Heat D, Edwards JE. The pathology of hypertensive pulmonary vascular disease.Circulation 1958;18:533-47.




2020     |     www.medigraphic.com